Jack Brown

2.3k total citations · 1 hit paper
64 papers, 1.6k citations indexed

About

Jack Brown is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Jack Brown has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 17 papers in Epidemiology and 9 papers in Pharmacology. Recurrent topics in Jack Brown's work include Antimicrobial Resistance in Staphylococcus (17 papers), Bacterial Identification and Susceptibility Testing (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Jack Brown is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (17 papers), Bacterial Identification and Susceptibility Testing (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Jack Brown collaborates with scholars based in United States, Germany and Ireland. Jack Brown's co-authors include Vivek S. Dave, Joseph A. Paladino, Alan Forrest, Fred Doloresco, Tina Khadem, Kristen Brown, Elizabeth Dodds Ashley, Vanessa Stevens, Joseph M. Mylotte and Charles G. Watson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Jack Brown

60 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches

2015 343 citations Jack Brown et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jack Brown United States	22	546	380	261	261	193	64	1.6k
Mark Gilchrist United Kingdom	23	750 1.4×	572 1.5×	286 1.1×	234 0.9×	65 0.3×	48	2.4k
Francisco Molina Spain	23	369 0.7×	493 1.3×	161 0.6×	52 0.2×	170 0.9×	103	1.8k
Timothy M. Rawson United Kingdom	26	1.1k 2.0×	856 2.3×	313 1.2×	357 1.4×	159 0.8×	92	3.7k
Alison H. Thomson United Kingdom	27	334 0.6×	390 1.0×	831 3.2×	159 0.6×	49 0.3×	78	2.5k
Scott E. Walker Canada	26	194 0.4×	311 0.8×	523 2.0×	142 0.5×	43 0.2×	142	2.5k
Laurens Manning Australia	24	481 0.9×	363 1.0×	198 0.8×	127 0.5×	67 0.3×	159	2.1k
Scott Penzak United States	31	1.0k 1.8×	605 1.6×	350 1.3×	63 0.2×	59 0.3×	99	3.1k
Daniel González United States	28	360 0.7×	377 1.0×	846 3.2×	114 0.4×	61 0.3×	141	2.6k
Stefan Hagel Germany	22	691 1.3×	753 2.0×	225 0.9×	294 1.1×	23 0.1×	125	1.9k
Maddalena Peghin Italy	28	994 1.8×	749 2.0×	334 1.3×	191 0.7×	39 0.2×	89	2.4k

Countries citing papers authored by Jack Brown

Since Specialization

Citations

This map shows the geographic impact of Jack Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Brown more than expected).

Fields of papers citing papers by Jack Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Brown. The network helps show where Jack Brown may publish in the future.

Co-authorship network of co-authors of Jack Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Brown. A scholar is included among the top collaborators of Jack Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Brown. Jack Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abraham, Edward, Guido Guidotti, Eliezer Rapaport, et al.. (2021). Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2. Purinergic Signalling. 17(3). 399–410. 11 indexed citations

Brown, Jack. (2018). An Alternative War: The Development, Impact, and Legality of Hybrid Warfare Conducted by the Nation State. SHILAP Revista de lepidopterología. 5(1-2). 1 indexed citations

Khadem, Tina, et al.. (2015). New Thoughts on the “Forgotten” Aspect of Antimicrobial Stewardship: Adverse Event Reporting. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 35(1). 59–63. 1 indexed citations

Khadem, Tina, et al.. (2014). How Safe Are Recently FDA‐Approved Antimicrobials? A Review of the FDA Adverse Event Reporting System Database. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(12). 1324–1329. 6 indexed citations

Khadem, Tina, et al.. (2014). Information Literacy Skills Retention Over the First Professional Year of Pharmacy School. Medical Reference Services Quarterly. 33(3). 302–312. 7 indexed citations

Goff, Debra A., et al.. (2013). A Stewardship Program’s Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis. Clinical Therapeutics. 35(6). 772–779. 55 indexed citations

Turner, Stuart, Jack Brown, & Joseph A. Paladino. (2013). Protease Inhibitors for Hepatitis C: Economic Implications. PharmacoEconomics. 31(9). 739–751. 3 indexed citations

Prescott, William A., et al.. (2013). Inhaled aztreonam lysine: an evidence-based review. Expert Opinion on Pharmacotherapy. 14(15). 2115–2124. 12 indexed citations

Soon, Rachel L., Stuart Turner, Alan Forrest, Brian T. Tsuji, & Jack Brown. (2013). Pharmacokinetic/pharmacodynamic evaluation of the efficacy and safety of daptomycin against Staphylococcus aureus. International Journal of Antimicrobial Agents. 42(1). 53–58. 17 indexed citations

10.

Khadem, Tina, et al.. (2013). A review of tuberculosis: Focus on bedaquiline. American Journal of Health-System Pharmacy. 70(22). 1984–1994. 34 indexed citations

11.

Brown, Jack, et al.. (2013). Rapid testing for methicillin-resistant Staphylococcus aureus: Implications for antimicrobial stewardship. American Journal of Health-System Pharmacy. 70(4). 335–342. 10 indexed citations

12.

Stevens, Vanessa, Thomas P. Lodise, Brian T. Tsuji, et al.. (2012). The Utility of Acute Physiology and Chronic Health Evaluation II Scores for Prediction of Mortality among Intensive Care Unit (ICU) and Non-ICU Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia. Infection Control and Hospital Epidemiology. 33(6). 558–564. 24 indexed citations

13.

Brown, Jack, et al.. (2011). Potential for Linezolid‐Related Blindness: A Review of Spontaneous Adverse Event Reports. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(6). 585–590. 4 indexed citations

14.

Stevens, Vanessa, et al.. (2011). Streptococcus pneumoniae Vaccination in Older Adults. The American journal of geriatric pharmacotherapy. 9(6). 392–404. 8 indexed citations

15.

Brown, Jack, Kristen Brown, & Alan Forrest. (2011). Outcomes and Costs Associated With a History of Vancomycin Exposure in Patients With MRSA-Related Complicated Bacteremia and Infective Endocarditis. Clinical Therapeutics. 33(10). 1475–1482. 5 indexed citations

16.

Brown, Jack & Joseph A. Paladino. (2010). Impact of Rapid Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Testing on Mortality and Cost Effectiveness in Hospitalized Patients with Bacteraemia. PharmacoEconomics. 28(7). 567–575. 63 indexed citations

17.

Venuto, Charles S., Mary Butler, Elizabeth Dodds Ashley, & Jack Brown. (2010). Alternative Therapies for Clostridium difficile Infections. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(12). 1266–1278. 26 indexed citations

18.

Brown, Jack, Fred Doloresco, & Joseph M. Mylotte. (2009). “Never Events”: Not Every Hospital‐Acquired Infection Is Preventable. Clinical Infectious Diseases. 49(5). 743–746. 65 indexed citations

19.

Sakoulas, George, Jack Brown, Kenneth C. Lamp, Lawrence V. Friedrich, & Kimberly C. Lindfield. (2009). Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience. Clinical Therapeutics. 31(9). 1936–1945. 46 indexed citations

20.

Brown, Jack. (1978). Information Users versus Information Systems.. 35(6).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact